Nubad, LLC

Greenville, SC 29605

SBIR Award Summary

Total Number of Awards 14
Total Value of Awards $4.63MM
First Award Date 09/01/11
Most Recent Award Date 12/01/17

Key Personnel

Last Name Name Awards Contact
Arya Dev Priya Arya 12
SPANO MEREDITH NEWBY SPANO 2

14 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 12/01/17 - 11/30/18

PROJECT SUMMARY Aminoglycosides are one of the cheapest and well-known antibiotics in clinical use for over 70 years, but one of the major limitations in their use is their ototoxicity. We are developing fast and low cost methods to develop aminoglycosides with anti- ribosomal activities and reduced toxicity. In this project, we will identify n...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-15-270
Budget: 08/01/17 - 07/31/18

PROJECT SUMMARY Aminoglycosides are one of the cheapest and well-known antibiotics in clinical use for over 70 years, but one of the major limitations in their use is their ototoxicity. We are developing fast and low cost methods to develop aminoglycosides with anti- ribosomal activities and reduced toxicity. In this project, we will identify n...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-308
Budget: 07/01/17 - 06/30/18

? DESCRIPTION (provided by applicant): Nucleic acids are avenues for drug design, both as therapeutics and as targets. Here we propose to establish new methods for identifying antibiotic ribosome targets and lead compounds. Targeting specific RNA, such as rRNA which are involved in proliferation and survival of bacteria is a promising approac...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-15-270
Budget: 08/01/16 - 07/31/17

PROJECT SUMMARY Aminoglycosides are one of the cheapest and well-known antibiotics in clinicaluse for over 70 years, but one of the major limitations in their use is their ototoxicity. Weare developing fast and low cost methods to develop aminoglycosides with anti-ribosomal activities and reduced toxicity. In this project, we will identify novel...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-308
Budget: 07/13/16 - 06/30/17

? DESCRIPTION (provided by applicant): Nucleic acids are avenues for drug design, both as therapeutics and as targets. Here we propose to establish new methods for identifying antibiotic ribosome targets and lead compounds. Targeting specific RNA, such as rRNA which are involved in proliferation and survival of bacteria is a promising approach...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/16 - 02/28/17

? DESCRIPTION (provided by applicant): The world is rapidly heading towards a pre-1940's scenario when it comes to fighting infectious disease. Antimicrobial resistance is a growing problem on a global scale, greatly hampering our abilities to quell worldwide epidemics such as tuberculosis and malaria, as well as the simple staphylococcus inf...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 07/01/15 - 06/30/16

DESCRIPTION (provided by applicant): Some of the most significant therapies that treat disease target nucleic acids. Drugs that target nucleic acid include cancer drugs, antibiotics, and antivirals. Combined these classes of drugs have annual sales worldwide of ~$139 billion. Antibiotics that target nucleic acids account for $14.5 billion of the...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-14-077
Budget: 07/01/15 - 06/30/16

DESCRIPTION (provided by applicant): Some of the most significant therapies that treat disease target nucleic acids. Drugs that target nucleic acid include cancer drugs, antibiotics, and antivirals. Combined these classes of drugs have annual sales worldwide of ~$139 billion. Antibiotics that target nucleic acids account for $14.5 billion of the...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections. Targeting specific RNA, such as ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/15 - 02/29/16

DESCRIPTION (provided by applicant): The world is rapidly heading towards a pre-1940's scenario when it comes to fighting infectious disease. Antimicrobial resistance is a growing problem on a global scale, greatly hampering our abilities to quell worldwide epidemics such as tuberculosis and malaria, as well as the simple staphylococcus infectio...

Load More